# Host DNA Methylation for Endometrial Cancer Screening

> **NCT05290415** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 10000 (estimated)

## Conditions studied

- Cancer Screening
- Endometrial Cancer
- DNA Methylation
- Cervical Cytology
- Liquid Biopsy
- Cohort Study

## Interventions

- **DIAGNOSTIC_TEST:** DNA methylation testing

## Key facts

- **NCT ID:** NCT05290415
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-13
- **Primary completion:** 2022-06-13
- **Final completion:** 2022-09-13
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290415, "Host DNA Methylation for Endometrial Cancer Screening". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05290415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*